PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 30 results · Off-label Promotion · CNS & Neurology  · Clear
🔒 Subscribers only
AUTH/3768/5/23
Off-label Promotion Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Sandoz
A neurologist complained about Sandoz advance budgetary notification (ABN) materials (a full slide deck and a 2-page summary) for a natalizumab biosimilar for multiple sclerosis, before UK marketin…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3722/1/23
Off-label Promotion Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Otsuka
An anonymous, contactable complainant (representing a group of employees/former employees) complained about annual “Awareness, Trial, and Usage (ATU)” tracking market research commissioned by O…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3656/6/22
Off-label Promotion Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Teva
A health professional complained about a P3 Pharmacy article (an interview/profile involving a Teva senior leader) that mentioned Ajovy and Copaxone.Teva argued the piece was a third-party, biograp…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3606/1/22
Off-label Promotion Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Accord
A health professional complained about Accord UK Ltd’s promotion of the buprenorphine implant Sixmo 74.2mg after participating in market research for the campaign.The complainant alleged the camp…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3449/1/21
Off-label Promotion Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Small Pharma
An anonymous, contactable complainant challenged statements in a December 2020 Guardian article about DMT being trialled in the UK to treat depression.The article included a quotation attributed to…
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3344/5/20
Off-label Promotion Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Britannia Pharmaceuticals
A health professional said they had emailed Britannia Pharmaceuticals Ltd three times over 12 months asking to be removed from all mailing lists, but still received an emailed copy of Kinetic from …
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3360/6/20
Off-label Promotion Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Glenmark and iQ Pharma
An anonymous, non-contactable NHS employee complained about promotional material for Renocontin (prolonged release oxycodone hydrochloride) (ref PP-UK-REN-0002).The material was issued by CactusRx …
Clauses: 9.1,9.2,9.3
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3240/8/19
Off-label Promotion Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Colonis
Colonis Pharma Limited made a voluntary admission that a promotional letter (ref UK-CPL-121-008) about Melatonin 1mg/ml Oral Solution (indicated for short-term treatment of jet-lag in adults) inclu…
Clauses: 4.1,4.3
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3221/6/19
Off-label Promotion Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Colonis Pharma Limited — Melatonin 1mg/ml Oral Solution
An NHS trust medicines information pharmacist complained about a promotional letter (ref UK-CPL-121-008) sent by Colonis Pharma Limited promoting Melatonin 1mg/ml Oral Solution.The product was indi…
Clauses: 7.2,7.4,9.1
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3275/10/19
Off-label Promotion Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Britannia v Ever Pharma
Complainant: Britannia Pharmaceuticals complained about Ever Pharma’s promotion of Dacepton (apomorphine) for Parkinson’s disease motor fluctuations. Materials at issue: An email from an…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3149/1/19
Off-label Promotion Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Endo Ventures breached ABPI Code over
An anonymous complainant (a concerned UK health professional) challenged a fluoxetine advertisement (ref FLUO 0010/2018) placed in Pulse by Endo Ventures Ltd.The ad included the claim “for treatm…
Clauses: 4.1,4.2
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3036/4/18
Off-label Promotion Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Concordia
An anonymous contactable UK health professional complained about a journal advertisement for Morphgesic SR 10mg modified release morphine sulphate (ref Con/MOR/PM/0021) published in Pulse, April 20…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3123/11/18
Off-label Promotion Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Otsuka Europe voluntary admission
An Otsuka employee alleged Otsuka Europe was not transparent in its June 2018 response to the PMCPA in relation to earlier concerns about implementing SPC/prescribing information updates for Jinarc…
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3041/6/18
Off-label Promotion Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Employee complaint
An Otsuka employee complained that processes for updating SPCs and prescribing information were inadequate, leading to delayed communication/implementation and potential patient safety risk. Produc…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/2774/6/15
Off-label Promotion Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Pfizer gabapentin pharmacy “patient alert” on PMR systems
A head of medicines management (CCG) complained about a Pfizer-supported “patient alert” that appeared on some community pharmacy electronic dispensing/PMR systems when gabapentin was entered/d…
Clauses: NONE
2015 🔒 Subscribe
🔒 Subscribers only
AUTH/2535/10/12
Off-label Promotion Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Pfizer
A member of the public complained that Pfizer failed to warn consumers about serious side effects of Champix (varenicline), specifically convulsions/seizures, and alleged UK patient information was…
Clauses: NONE
2012 🔒 Subscribe
🔒 Subscribers only
AUTH/2439/9/11
Off-label Promotion Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
GP v Grünenthal
A general practitioner complained about a four-page dosing and titration leavepiece for Palexia SR (tapentadol prolonged release) issued by Grünenthal (ref P11 0066).Page 2 was headed: “Palexia …
Clauses: NONE
2011 🔒 Subscribe
🔒 Subscribers only
AUTH/2303/3/10
Off-label Promotion Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Flynn Pharma
ProStrakan complained about Flynn Pharma promotional materials for Actiq (oral transmucosal fentanyl citrate): a journal advertisement (International Journal of Palliative Nursing, Dec 2009; ref AC…
Clauses: NONE
2010 🔒 Subscribe
🔒 Subscribers only
AUTH/2327/6/10
Off-label Promotion Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
MHRA v Grünenthal
The MHRA alerted the PMCPA that it was concerned Grünenthal was promoting unlicensed tapentadol (Palexia) to health professionals before marketing authorisation.MHRA knew from earlier corresponden…
2010 🔒 Subscribe
🔒 Subscribers only
AUTH/2283/12/09
Off-label Promotion Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Lundbeck breached Clause 4.7 over prescribing information location statement size/placement in Cipra
An anonymous complainant challenged a two-page Cipralex (escitalopram) advertisement placed by Lundbeck in The Pharmaceutical Journal (28 November 2009).The ad included the statement “For referen…
Clauses: 4.7
2009 🔒 Subscribe
🔒 Subscribers only
AUTH/2274/10/09
Off-label Promotion Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Allergan “Neurology Pharmaceutical Survey” ruled disguised promotion for unlicensed headache/migrain
A consultant neurologist complained about a two-page “Neurology Pharmaceutical Survey” (22 questions) sent by a market research agency.The covering letter described it as a “marketing study�…
Clauses: NONE
2009 🔒 Subscribe
🔒 Subscribers only
AUTH/2087/1/08
Off-label Promotion Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Flynn Pharma
Flynn Pharma sent a “Dear Doctor” letter (18 November 2007) to approximately 3,000 paediatricians and 800 child psychiatrists, headed “Shortage of methylphenidate immediate release tablets”…
Clauses: NONE
2008 🔒 Subscribe
🔒 Subscribers only
AUTH/2022/7/07
Off-label Promotion Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
GP v Beacon Pharmaceuticals
A general practitioner complained about receiving repeated unsolicited “spam” emails, including an email relating to Episenta (prolonged release sodium valproate) sent on Beacon’s behalf.The …
Clauses: 9.1,9.2
2007 🔒 Subscribe
🔒 Subscribers only
AUTH/2021/7/07
Off-label Promotion Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Lundbeck
Two local health boards complained about a Lundbeck letter regarding Cipralex (escitalopram) and generalised anxiety disorder (GAD).The health boards alleged the letter misleadingly suggested they …
Clauses: NONE
2007 🔒 Subscribe
1 2 Next → Page 1 of 2 — 30 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews